Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report

Abstract

Lamotrigine is an anticonvulsant that appears to have a mainly antidepressant effect and is indicated for the maintenance treatment of bipolar depression. Literature associated with obsessional symptoms related to lamotrigine treatment is limited. We report the emergence of obsessive symptoms during treatment with lamotrigine in a patient who subsequently experienced significant improvement after dose reduction and stopping of this medication. The obsessive symptoms associated with lamotrigine treatment were observed after the lamotrigine dose was increased to 100 mg/day. The possible mechanisms, including inhibition on the presynaptic release of glutamate and alteration of striatal dopamine uptake, are discussed. It is unclear why lamotrigine induces obsessions in some patients. Controlled studies are necessary to identify the population at risk for obsessionality in bipolar illness following treatment with lamotrigine and to investigate a possible dose—response relationship between obsessive symptoms and lamotrigine.

Keywords

dopamine glutamate lamotrigine obsession

Get full access to this article

View all access options for this article.

References

Alkin, T. , Onur, E. , Ozerdem, A. ( 2007) Co-occurence of blepharospasm, tourettism and obsessive-compulsive symptoms during lamotrigine treatment. Prog Neuropsychopharmacol Biol Psychiatry 31: 1339-1340.

Bystritsky, A. , Ackerman, DL , Rosen, RM , Vapnik, T. , Gorbis, E. , Maidment, KM , et al. (2004) Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial. J Clin Psychiatry 65: 565-568.

Calabrese, J. , Bowden, C. , Sachs, G. , Yatham, LN , Behnke, K. , Mehtonen, OP , et al. (2003) A placebo-controlled, 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64: 1013-1024.

David, HN , Ansseau, M. , Abraini, JH ( 2005) Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals. Brain Res Rev 50: 336-360.

Denys, D. , Zohar, J. , Westenberg, HG ( 2004) The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 65: 11-17.

Goa, KL , Ross, SR , Chrisp, P. ( 1993) Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46: 152-176.

Goodman, WK , Price, LH , Rasmussen, SA , Mazure, C. , Fleischmann, RL , Hill, CL , et al. (1989) The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46: 1006-1011.

Goodwin, GM , Bowden, CL , Calabrese, JR , Grunze, H. , Kasper, S. , White, R. , et al. (2004) A pooled analysis of 2 placebocontrolled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder . J Clin Psychiatry 65: 432-441.

Grant, P. , Lougee, L. , Hirschtritt, M. , Swedo, SE ( 2007) An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J Child Adolesc Psycho-pharmacol 17: 761-767.

10.

Hamilton, M. ( 1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.

11.

Kemp, DE , Gilmer, WS , Fleck, J. , Dago, PL ( 2007) An association of intrusive, repetitive phrases with lamotrigine treatment in bipolar II disorder. CNS Spectr 12: 106-111.

12.

Lombroso, CT ( 1999) Lamotrigine-induced tourettism. Neurology 52: 1191-1194.

13.

Lykouras, L. , Zervas, IM , Gournellis, R. , Malliori, M. , Rabavilas, A. ( 2000) Olanzapine and obsessive-compulsive symptoms. Eur Neuropsychopharmacol 10: 385-387.

14.

Morari, M. , Marti, M. , Sbrenna, S. , Fuxe, K. , Bianchi, C. , Beani, L. ( 1998) Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem Int 33: 383-397.

15.

Potenza, MN , McDougle, CJ ( 1998) Potential of atypical antipsychotics in the treatment of non-psychotic disorders. CNS Drugs 9: 213-232.

16.

Rosenberg, DR , Mirza, Y. , Russell, A. , Tang, J. , Smith, JM , Banerjee, SP , et al. (2004) Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls . J Am Acad Child Adolesc Psychiatry 43: 1146-1153.

17.

Saxena, S. , Rauch, SL ( 2000) Functional neuroimaging and the neuro-anatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 23: 563-586.

18.

Sidhu, J. , Job, S. , Bullman, J. , Francis, E. , Abbott, R. , Ascher, J. , et al. (2006) Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects. Br J Clin Pharmacol 61: 420-426.

19.

Sotero de Menezes, MA , Rho, JM , Murphy, P. , Cheyette, S. ( 2000) Lamotrigine-induced tic disorder: report of five pediatric cases. Epilepsia 41: 862-867.